These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7683364)

  • 1. Non-opioid antitussives potentiate some behavioural and EEG effects of N-methyl-D-aspartate channel blockers.
    Diana G; Scotti de Carolis A; Popoli P; Pezzola A; Sagratella S
    Life Sci; 1993; 52(19):1547-57. PubMed ID: 7683364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different capability of N-methyl-D-aspartate antagonists to elicit EEG and behavioural phencyclidine-like effects in rats.
    Sagratella S; Pezzola A; Popoli P; Scotti de Carolis AS
    Psychopharmacology (Berl); 1992; 109(3):277-82. PubMed ID: 1365627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diphenylhydantoin potentiates the EEG and behavioural effects induced by N-methyl-D-aspartate antagonists in rats.
    Popoli P; Pèzzola A; Sagratella S
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):471-5. PubMed ID: 7862861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat.
    Klamer D; Zhang J; Engel JA; Svensson L
    Behav Brain Res; 2005 Apr; 159(1):95-103. PubMed ID: 15795002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan.
    Chou YC; Liao JF; Chang WY; Lin MF; Chen CF
    Brain Res; 1999 Mar; 821(2):516-9. PubMed ID: 10064839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of NMDA and sigma systems in the behavioral effects of phencyclidine in preweanling rats.
    Scalzo FM; Burge LJ
    Neurotoxicology; 1994; 15(1):191-200. PubMed ID: 8090359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dextromethorphan and dextrorphan in rats: common antitussives--different behavioural profiles.
    Dematteis M; Lallement G; Mallaret M
    Fundam Clin Pharmacol; 1998; 12(5):526-37. PubMed ID: 9794151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the reinforcing properties and phencyclidine-like discriminative stimulus effects of dextromethorphan and dextrorphan in rats and rhesus monkeys.
    Nicholson KL; Hayes BA; Balster RL
    Psychopharmacology (Berl); 1999 Sep; 146(1):49-59. PubMed ID: 10485964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus properties of dextromethorphan in rats.
    Gavend M; Mallaret M; Dematteis M; Baragatti G
    Biomed Pharmacother; 1995; 49(10):456-64. PubMed ID: 8746072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dextromethorphan potentiates morphine antinociception at the spinal level in rats.
    Chow LH; Huang EY; Ho ST; Lee TY; Tao PL
    Can J Anaesth; 2004 Nov; 51(9):905-10. PubMed ID: 15525615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of caramiphen and phencyclidine alone and in combination on behavior in the rat.
    Székely JI; Sharpe LG; Katz JL
    Pharmacol Biochem Behav; 1994 Mar; 47(3):709-13. PubMed ID: 8208792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonists at the NMDA recognition site and blockers of the associated ion channel induce spontaneous tail-flicks in the rat.
    Millan MJ
    Eur J Pharmacol; 1991 Oct; 203(2):315-8. PubMed ID: 1724759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats.
    Wlaź P; Ebert U; Potschka H; Löscher W
    Eur J Pharmacol; 1998 Jul; 353(2-3):177-89. PubMed ID: 9726648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
    Witkin JM; Steele TD; Sharpe LG
    J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MK-801, phencyclidine (PCP), and PCP-like drugs increase burst firing in rat A10 dopamine neurons: comparison to competitive NMDA antagonists.
    French ED; Mura A; Wang T
    Synapse; 1993 Feb; 13(2):108-16. PubMed ID: 8446919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MK-801, but not naloxone, attenuates high-dose dextromethorphan-induced convulsive behavior: Possible involvement of the GluN2B receptor.
    Tran HQ; Chung YH; Shin EJ; Tran TV; Jeong JH; Jang CG; Nah SY; Yamada K; Nabeshima T; Kim HC
    Toxicol Appl Pharmacol; 2017 Nov; 334():158-166. PubMed ID: 28916251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents.
    Bristow LJ; Hutson PH; Thorn L; Tricklebank MD
    Br J Pharmacol; 1993 Apr; 108(4):1156-63. PubMed ID: 8485625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticonvulsant properties of non-competitive antagonists of the N-methyl-D-aspartate receptor in genetically epilepsy-prone rats: comparison with CPPene.
    De Sarro GB; De Sarro A
    Neuropharmacology; 1993 Jan; 32(1):51-8. PubMed ID: 8094234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-methyl-D-aspartate receptors in associative eyeblink conditioning: both MK-801 and phencyclidine produce task- and dose-dependent impairments.
    Thompson LT; Disterhoft JF
    J Pharmacol Exp Ther; 1997 May; 281(2):928-40. PubMed ID: 9152403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (+)-SKF-10,047 and dextromethorphan ameliorate conditioned fear stress through the activation of phenytoin-regulated sigma 1 sites.
    Kamei H; Kameyama T; Nabeshima T
    Eur J Pharmacol; 1996 Mar; 299(1-3):21-8. PubMed ID: 8901003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.